Clinical trial
Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis
NCT00294125 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00294125 |
|---|---|
| Title | Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis |
| Official title | Flavocoxid: A Medical Food Therapy for Osteoarthritis |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Primus Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Flavocoxid, Placebo |
| Enrollment | 59 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 20, 2006 |
| Last update posted | Apr 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: